Eton Pharmaceutical | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Harrow, Inc.(0.0%)
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Gruber James R.
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer BRYNJELSEN SEAN
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director Adams Jennifer McKie
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director CASAMENTO CHARLES J
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director RIEDEL NORBERT G
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director MAIER PAUL V
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Krempa David
Eton Pharmaceutical | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Opaleye Management, Inc.(9.84%)
Eton Pharmaceutical | 3: Initial statement of beneficial ownership of securities-Officer Krempa David
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director CASAMENTO CHARLES J
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director RIEDEL NORBERT G
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director MAIER PAUL V
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer BRYNJELSEN SEAN
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Gruber James R.
Eton Pharmaceutical | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Opaleye Management, Inc.(8.58%)
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities
Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities
Eton Pharmaceutical | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Gruber James R.
No Data